Rutgers Cancer Institute shared on LinkedIn:
“Research from Rutgers Cancer Institute and RWJBarnabas Health suggests that a shorter, three-week course of radiation therapy may be an effective option for some women undergoing breast cancer treatment, compared with the traditional five-week schedule.
Dr. Bruce Haffty, associate Vice Chancellor for Cancer Programs at Rutgers Cancer Institute and an investigator on both the current and past related studies, discusses the findings and what they could mean for patients.”
Dr. Bruce Haffty discusses the findings of a nationwide randomized study involving nearly 900 women, explaining how a three-week radiation therapy regimen proved safe and effective for patients undergoing breast reconstruction. He also highlights how earlier research at Rutgers Cancer Institute helped lay the foundation for the larger trial and shares what the findings could mean for future post-mastectomy radiation treatment decisions.
Title: Randomized Trial of Hypofractionated Postmastectomy Radiation Therapy in Women With Breast Reconstruction (RT CHARM, Alliance A221505)
Authors: Matthew M. Poppe, Jennifer J. Le-Rademacher, Bruce G. Haffty, Eric K. Hansen, Jayant P. Agarwal, Jamie L. Wagner, Iwa Kong, Jane M. Armer, Doug W. Arthur, Timothy J. Whelan, Odum Kour, Minji K. Lee, Kathryn J. Ruddy, Ann H. Partridge, Lisa A. Carey, Maryam Lustberg, Michael B. Bernstein, Selina L. Chow, Shane R. Stecklein, David K. Gaffney, Atif J. Khan
Read the Full Article on Journal of Clinical Oncology
You can also read: Breast Cancer Treatment in 2026: Precision Is Expanding While Surgery and Radiation Become More Selective
